GLOSTRUP, Denmark, Feb. 28, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics , today announced it has added the new Jenner-Wright Giemsa stain to its Dako Artisan TM Link portfolio, the broadest palette of automated stains.
Dako is releasing the stain in its continuing mission to provide pathology labs around the world with the most advanced special stain solutions and the broadest portfolio of stains. The stain, available only from Dako, will be commercially available March 3.
The Jenner-Wright Giemsa stain is designed to provide clear differentiation and detail of the hematopoietic cells in bone marrow tissue samples for the diagnosis of cancer, aplastic anemia and myelofibrosis. The stain gives pathologists an added dimension to the visualization of the cell morphology.
Dako's Artisan(TM) portfolio provides the broadest range of automated special stains available. The portfolio, consisting now of 31 high-quality stains, covers nearly all of a typical lab's special stain needs. It also enables labs to take advantage of the productivity benefits possible through automation with the Artisan(TM) Link Pro instrument.
"Dako's Jenner-Wright Giemsa special stain for bone marrow is excellent, and allows us, for the first time, to automate the diagnosis of various diseases using bone marrow tissue," said Professor Hermann Herbst, director of the Vivantes Pathology Department in Berlin. "Artisan(TM) Link Pro stains are fabulous to look at. This stain in particular offers an unprecedented ability to use bone marrow and provides exceptionally clear differentiation and detail."
Laboratories that routinely do special stains will also benefit from a 64 percent reduction in hands-on time with Artisan(TM) Link Pro, compared with the same protocols performed manually. Significant gains in lab safety can also be realized because the Artisan(TM) Link Pro and its RTU reagents are closed, minimizing the exposure to hazardous chemicals, and can be connected to ventilation systems. The instrument also features a unique waste separation system that reduces hazardous waste generation to help labs minimize the cost of disposal.
Dako plans to continue adding more stains to the portfolio.
Dako Denmark A/S
Maia Fredtoft Søchting
Dako Denmark A/S
About Dako - An Agilent Technologies Company
Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako's reagents, instruments, software and expertise to make accurate diagnoses and determine the most effective treatment for cancer patients. Dako became part of Agilent Technologies in 2012. Information about Dako is available at www.dako.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.
On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.
Source: Dako Denmark A/S